Carfilzomib is contraindicated in patients with known hypersensitivity to the drug or its components. Caution is advised in patients with pre-existing heart conditions, as the risk of cardiovascular events is elevated. Additionally, it is not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant.
